1,8-Dihydroxy-3-Methoxy-Anthraquinone Inhibits Tumor Angiogenesis Through HIF-1α Downregulation

Investigators conducted comprehensive investigations utilizing human colorectal cancer HCT116 cells, human umbilical cord vascular endothelial cells, and zebrafish embryos to assess the potential benefits of DMA in suppressing tumor angiogenesis.